Clinical trial
Transepidermal Application of Metilaminolevulinate in Daylight Photodynamic Therapy in the Treatment of Photodamaged Skin
NCT03963765 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transepidermal Application of Metilaminolevulinate in Daylight Photodynamic Therapy in the Treatment of Photodamaged Skin
- Lead sponsor
- Universidade Federal Fluminense
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 3, 2017
- Completion date
- December 1, 2020
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.